Healthcare company Sanofi Aventis France said it had been placed under formal investigation on charges of manslaughter over Depakine, which is an epilepsy drug that caused birth malfunctions and slow neurological development when taken during pregnancy, reports Reuters.
Sanofi Aventis France denied the charges and is challenging the merits of the investigation, it said in a written statement to Reuters.
“All these elements do not in any way prejudge the responsibility of the company,” Sanofi Aventis France said.
The company said it had respected all its obligations regarding information provided on Depakine.
Sanofi Aventis France denied the charges and is challenging the merits of the investigation, it said in a written statement to Reuters.
“All these elements do not in any way prejudge the responsibility of the company,” Sanofi Aventis France said.
The company said it had respected all its obligations regarding information provided on Depakine.